Previous Page  8 / 19 Next Page
Information
Show Menu
Previous Page 8 / 19 Next Page
Page Background

EMEA guidelines for biosimilars authorization

Recombinant

Rituxi, etc.

Guideline on Similar Biological Products Containing Biotechnology-

derived Proteins as Active Substance:

Quality Issues

Guideline on Similar Biological Products Containing

Biotechnology-derived Proteins as Active Substance:

Non-Clinical and Clinical Issues

recombinant

Erythro, G-CSF

Recombinant

Trastu, Beva,

recombinant

hGH, insulin

General

Calidad

Estudios

preclínicos y

clínicos

Anexos y

actualizaciones

Guideline on

Similar Biological Medicinal Products